Positive association of collagen type I with non-muscle invasive bladder cancer progression
Author(s) -
Michael Brooks,
Qianxing Mo,
Ross Krasnow,
Philip Levy Ho,
YuCheng Lee,
Jing Xiao,
Antonina V. Kurtova,
Seth P. Lerner,
Gui Godoy,
Weiguo Jian,
Patricia Castro,
Fengju Chen,
David R. Rowley,
Michael Ittmann,
Keith Syson Chan
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.12089
Subject(s) - bladder cancer , medicine , tumor progression , extracellular matrix , cancer , immunohistochemistry , type i collagen , pathology , proportional hazards model , oncology , biology , microbiology and biotechnology
Non-muscle invasive bladder cancers (NMIBC) are generally curable, while ~15% progresses into muscle-invasive cancer with poor prognosis. While efforts have been made to identify genetic alternations associated with progression, the extracellular matrix (ECM) microenvironment remains largely unexplored. Type I collagen is a major component of the bladder ECM, and can be altered during cancer progression. We set out to explore the association of type I collagen with NMIBC progression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom